Join the Meeting Place for Moms!
Talk to other moms, share advice, and have fun!

(minimum 6 characters)

Diabetes Drug under Fire

Posted by on Jul. 12, 2010 at 4:18 PM
  • 1 Replies

 

By Susan Heavey Susan Heavey - Mon Jul 12, 12:05 pm ET

WASHINGTON (Reuters) - Lawyers for patients who say they have been harmed by GlaxoSmithKlinePlc's Avandia say critical data is still under wraps even as a U.S. advisory panel prepares to weigh the fate of the controversial diabetes drug.

The lawyers, who represent thousands of patients or family members suing the British drugmaker in multi-district federal litigation, say they have uncovered critical documents.

They are pushing the court to allow their release to both the U.S. Food and Drug Administration and the Senate Finance Committee, which has investigated Glaxo's handling of Avandia.

An FDA advisory panel is already wading through hundreds of pages of conflicting data and studies, and is due to meet for two days starting Tuesday on whether to recommend that Avandia be pulled off the market due to heart risks.

Avandia has been under fire since 2007 over concerns that it raises the risk of heart attack, strokeand death more than Takeda Pharmaceutical Co's rival diabetes pill Actos.

Full Article Here

For the debate.

If pharmaceutical drugs have the potential to cause death, should they still be allowed to be dispensed? Is it up to the consumer to decide if they are willing to take that risk? If they choose to take the risk and die, should their families be able to sue the company?

    Different, but not less~Temple Grandin

by on Jul. 12, 2010 at 4:18 PM
Add your quick reply below:
You must be a member to reply to this post.
Replies (1-1):
TruthSeeker.
by Milami on Jul. 12, 2010 at 5:39 PM

 Anyone?

Add your quick reply below:
You must be a member to reply to this post.
Join the Meeting Place for Moms!
Talk to other moms, share advice, and have fun!

(minimum 6 characters)